PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

IRCM researchers identify a protein that controls the 'guardian of the genome'

A study sheds new light on a well-known mechanism required for the immune response

2014-12-05
(Press-News.org) Montréal, December 5, 2014 - A new study published in the scientific journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) sheds new light on a well-known mechanism required for the immune response. Researchers at the IRCM, led by Tarik Möröy, PhD, identified a protein that controls the activity of the p53 tumour suppressor protein known as the "guardian of the genome".

The researchers study the development of T cells and B cells, which are lymphocytes (or immune cells) that play a central role in protecting our body against infections by viruses, bacteria and other microbial agents.

"As these lymphocytes develop, they must learn how to recognize different pathogens in the body," says Dr. Möröy, Director of the Hematopoiesis and Cancer research unit at the IRCM. "Part of this process involves the breaking and rearranging of the genes responsible for producing the lymphocyte receptors that recognize these pathogens. However, when a cell's genome contains too many breaks, p53 (the "guardian of the genome") gets alerted and causes the cell to die."

"In developing immune cells, activation of p53 must be contained to avoid their premature death," explains Marissa Rashkovan, first author of the study and doctoral student in Dr. Möröy's laboratory. "We discovered that a protein called Miz-1 can exert such a function by controlling the activity of p53. More specifically, Miz-1 controls the way in which p53 gets alerted when a cell needs to die. In fact, without Miz-1, developing lymphocytes always activate the p53 protein and, hence, never survive."

"Our study therefore helps advance our understanding of how an efficient immune response is built in our body," adds Dr. Möröy, who is also the IRCM's President and Scientific Director. "Our results show that, by controlling the activity of p53 and preventing premature cell death, Miz-1 ensures the survival of lymphocytes during their critical phase of development and, thereby, the proper functioning of our immune system."

INFORMATION:

About the study IRCM authors for the article published in PNAS include Marissa Rashkovan, Charles Vadnais, Julie Ross, Christian Kosan and Tarik Möröy (Director) from the Hematopoiesis and Cancer research unit, as well as Mathieu Gigoux and Woong-Kyung Suh (Director) from the Immune Regulation research unit. The researchers also collaborated with Wei Gu from Columbia University. The study was funded by grants from the Canadian Institutes of Health Research (CIHR), the Canada Research Chair program and the Cole Foundation.

For more information on this discovery, please refer to the article summary published online by PNAS: http://www.pnas.org/content/early/2014/12/02/1412107111.abstract.

About Tarik Möröy Tarik Möröy obtained a PhD in biochemistry from the Ludwig-Maximilians University in Munich, Germany. He is the IRCM's President and Scientific Director, Full IRCM Research Professor and Director of the Hematopoiesis and Cancer research unit. Dr. Möröy is also Full Research Professor in the Department of Microbiology, Infectiology and Immunology at the Université de Montréal, and Adjunct Professor in the Department of Medicine (Division of Experimental Medicine) at McGill University. Dr. Möröy holds the Canada Research Chair in Hematopoiesis and Immune Cell Differentiation. For more information, visit http://www.ircm.qc.ca/moroy.

About the IRCM The IRCM is a renowned biomedical research institute located in the heart of Montréal's university district. Founded in 1967, it is currently comprised of 35 research units and four specialized research clinics (cholesterol, cystic fibrosis, diabetes and obesity, hypertension). The IRCM is affiliated with the Université de Montréal, and the IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). It also maintains a long-standing association with McGill University. The IRCM is funded by the Quebec ministry of Economy, Innovation and Export Trade (Ministère de l'Économie, de l'Innovation et des Exportations).



ELSE PRESS RELEASES FROM THIS DATE:

Drugs in the environment affect plant growth

2014-12-05
The drugs we release into the environment are likely to have a significant impact on plant growth, a new study has revelealed. By assessing the impacts of a range of non-steroidal anti-inflammatory drugs, researchers at the University of Exeter Medical School and Plymouth University have shown that the growth of edible crops can be affected by these chemicals - even at the very low concentrations found in the environment. Published in the Journal of Ecotoxicology and Environmental Safety, the research focused its analysis on lettuce and radish plants and tested the ...

Salience network is linked to brain disorders

2014-12-05
CORAL GABLES, Fla (December 4, 2014) -- How does the brain determine what matters? According to a new scientific article, a brain structure called the insula is essential for selecting things out of the environment that are "salient" for an individual, and dysfunction of this system is linked to brain disorders such as autism, psychosis and dementia. In psychology and neuroscience, the term "salient" is used to describe a thing, person, place or event that stands out, or that is set apart from others. The current article, published online by Nature Reviews Neuroscience ...

Apixaban in DVT and pulmonary embolism: Patients with high BMI benefit considerably

2014-12-05
Apixaban (trade name Eliquis) has been approved since July 2014 for acute treatment of adults with deep vein thrombosis or pulmonary embolism. In addition, the drug can be used for low-dose long-term treatment to prevent recurrent thrombosis or pulmonary embolism. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether in these cases the drug offers patients an added benefit over the appropriate comparator therapies. According to the findings, considerable added benefit of apixaban is proven for the initial treatment ...

Social networking during a campus emergency

2014-12-05
Emergencies at educational establishments are on the increase in recent years and campus officials are beginning to recognize that better communications with their students are now needed. Writing in the International Journal of Business Information Systems, US researchers describe how social networking sites might be exploited when an emergency situation arises to help safeguard students as well as keeping those not directly involved in the situation informed of events. The same insights might be applied in the business environment too. Wencui Han of the Department of ...

Looking at El Niño's past to predict its future

2014-12-05
The El Niño Southern Oscillation is Earth's main source of year-to-year climate variability, but its response to global warming remains highly uncertain. Scientists see a large amount of variability in the El Niño-Southern Oscillation (ENSO) when looking back at climate records from thousands of years ago. Without a clear understanding of what caused past changes in ENSO variability, predicting the climate phenomenon's future is a difficult task. A new study shows how this climate system responds to various pressures, such as changes in carbon dioxide and ice ...

Can anyone be a journalist? UGA researcher examines citizen journalism

Can anyone be a journalist? UGA researcher examines citizen journalism
2014-12-05
Athens, Ga. - A new article detailing the relationship of two U.S. Supreme Court cases and how they work together to uphold freedom of expression has been published in the Georgia Law Review by William E. Lee, professor of journalism in the University of Georgia Grady College of Journalism and Mass Communication. Lee's article focuses on New York Times v. Sullivan and its companion case, Abernathy v. Sullivan, in which the court upheld the First Amendment rights of both the press and ministers active in the civil rights movement. These rulings affect today's citizen ...

Why CLL there are often relapses after treatment

2014-12-05
Chronic lymphocytic leukemia (CLL) is among the most frequent leukemias affecting adults in Western countries. It usually occurs in older patients, does not cause any symptoms for a long time and is often only discovered by accident. Despite treatment, relapses frequently occur. The immunologists Dr. Kristina Heinig and Dr. Uta Höpken (Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch) and the hematologist Dr. Armin Rehm (MDC and Charité - Universitätsmedizin Berlin) have now discovered why this is so. In a mouse model they developed, the ...

Light propagation in solar cells made visible

Light propagation in solar cells made visible
2014-12-05
This news release is available in German. How can light which has been captured in a solar cell be examined in experiments? Jülich scientists have succeeded in looking directly at light propagation within a solar cell by using a trick. The photovoltaics researchers are working on periodic nanostructures that efficiently capture a portion of sunlight which is normally only poorly absorbed. Until recently, light trapping within periodically nanostructured solar cells could only be analysed using indirect methods, as captured light is not visible from outside ...

NIST study 'makes the case' for RFID forensic evidence management

2014-12-05
Radio frequency identification (RFID) tags--devices that can transmit data over short distances to identify objects, animals or people--have become increasingly popular for tracking everything from automobiles being manufactured on an assembly line to zoo animals in transit to their new homes. Now, thanks to a new NIST report, the next beneficiaries of RFID technology may soon be law enforcement agencies responsible for the management of forensic evidence. A typical RFID system consists of a microchip programmed with identifying data--the "tag"--and a two-way radio transmitter-receiver, ...

Poor semen quality linked to hypertension, other health problems, Stanford study finds

2014-12-05
A study of more than 9,000 men with fertility problems has revealed a correlation between the number of different defects in a man's semen and the likelihood that the man has other health problems. The study, conducted by investigators at the Stanford University School of Medicine, also links poor semen quality to a higher chance of having various specific health conditions, such as hypertension, and more generally to skin and endocrine disorders. The findings, to be published online Dec. 10 in Fertility and Sterility, may spur more-comprehensive approaches to treating ...

LAST 30 PRESS RELEASES:

Effectiveness and safety of tenofovir amibufenamide in the treatment of chronic hepatitis B: A real-world, multicenter study

Higher costs limit attendance for life changing cardiac rehab

Over 500 patients receive diagnosis through genetic reanalysis

Brain changes in Huntington’s disease decades before diagnosis will guide future prevention trials

U of A astronomers capture unprecedented view of supermassive black hole in action

Astrophysicists reveal structure of 74 exocomet belts orbiting nearby stars in landmark survey

Textbooks need to be rewritten: RNA, not DNA, is the main cause of acute sunburn

Brits still associate working-class accents with criminal behavior – study warns of bias in the criminal justice system

What do you think ‘guilty’ sounds like? Scientists find accent stereotypes influence beliefs about who commits crimes

University of Calgary nursing study envisions child trauma treatment through a Marvel and DC lens

Research on performance optimization of virtual data space across WAN

Researchers reveal novel mechanism for intrinsic regulation of sugar cravings

Immunological face of megakaryocytes

Calorie labelling leads to modest reductions in selection and consumption

The effectiveness of intradialytic parenteral nutrition with ENEFLUID???? infusion

New study reveals AI’s transformative impact on ICU care with smarter predictions and transparent insights

Snakes in potted olive trees ‘tip of the iceberg’ of ornamental plant trade hazards

Climate change driving ‘cost-of-living' squeeze in lizards

Stem Cell Reports seeks applications for its Early Career Scientist Editorial Board

‘Brand new physics’ for next generation spintronics

Pacific Islander teens assert identity through language

White House honors Tufts economist

Sharp drop in mortality after 41 weeks of pregnancy

Flexible electronics integrated with paper-thin structure for use in space

Immune complex shaves stem cells to protect against cancer

In the Northeast, 50% of adult ticks carry Lyme disease carrying bacteria

U of A Cancer Center clinical trial advances research in treatment of biliary tract cancers

Highlighting the dangers of restricting discussions of structural racism

NYU Tandon School of Engineering receives nearly $10 million from National Telecommunications and Information Administration

NASA scientists find new human-caused shifts in global water cycle

[Press-News.org] IRCM researchers identify a protein that controls the 'guardian of the genome'
A study sheds new light on a well-known mechanism required for the immune response